Bioscience in Oklahoma truly is driving innovation that is improving lives and creating jobs! Here is a look at some of our emerging bio companies:

• Ascend BioVentures is a pharmaceutical accelerator that guides promising drug candidates through the riskiest, early stages of development. ABV helps identify innovative and transformative therapeutics and works to efficiently launch companies focused on preclinical drug development.
• Linear Health Sciences is a medical device company that has developed a proprietary, breakaway safety valve technology designed to improve the use of medical tubing in hospitals. Recently, Linear received U.S. FDA clearance and Health Canada approval of its Orchid SRV™, a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.
• Moleculera Labs is a pioneer in infection-induced autoimmune conditions that disrupt neurologic function. The company currently markets next-generation antibody tests that detect whether an autoimmune reaction is causing neurologic or psychiatric symptoms.
• Cytovance Biologics, Inc. is a pharmaceutical contract manufacturer producing biologics, therapeutic proteins and antibodies. The company employs more than 200, and their products are used globally for clinical trials and research.
• Immuno Mycologics is listed as one of Inc.’s fastest-growing private companies in the nation. IMMY is a diagnostic manufacturing company that has evolved from a company that filled a need in the infectious disease market to an organization with a global focus on saving lives through innovative products.
• MS Pen Technologies, Inc. is a medical device company commercializing innovative mass spectrometry solutions for molecular analysis at the point of need. The Preciso MasSpecPen, when exposed to a tissue surface and connected to a mass spectrometer can identify the molecular profile of cancerous tissues in real time. The technology is potentially extensible to pathology, robotics, forensic, botanical, and food safety applications, among others.
• Otologic Pharmaceuticals is developing pharmaceuticals to combat hearing loss and hearing-related disorders, like tinnitus. Otologic has two programs focused on therapeutics that protect and repair damage in the ear as well as a regenerative medicine approach focused on re-growing inner hair cells.  Otologic has a license deal with Oblato for the development of their clinical stage drug and they recently signed a research collaboration and license agreement with Boehringer Ingelheim to discover, develop, and commercialize transformative therapies for patients with sensorineural hearing loss.
• Progentec Diagnostics, Inc. has developed an advanced state-of-the-art Lupus flare diagnostic, which has potential to fundamentally change the current treatment paradigm for Lupus.  The company has partnered with the Oklahoma Medical Research Foundation, a Center of Excellence for Lupus in the US and they are striving to accelerate commercialization of the patented diagnostic technology.
• Biolytx is a pharmaceutical technology company developing a novel antibiotic peptide for potential use in wound healing and treatment of serious hospital-acquired infections, including those resistant to current antibiotics. The technology was developed in the University of Oklahoma Health Sciences Center laboratory of Dr. Anne Pereira and licensed from OU.
• Tetherex Pharmaceuticals, a clinical-stage drug development company, was formed to develop novel first-in-class therapeutics targeting cell adhesion proteins in thrombotic, inflammatory and oncologic diseases.